BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8055443)

  • 21. Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide.
    Mizutani Y; Fukumoto M; Bonavida B; Yoshida O
    Cancer; 1994 Nov; 74(9):2546-54. PubMed ID: 7923012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression and significance of P-glycoprotein, glutathione S-transferase-pi and Topoisomerase II in gastric carcinomas].
    Qin F; Qin X; Zhang X; Jia HW
    Ai Zheng; 2002 Feb; 21(2):167-70. PubMed ID: 12479068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition by 5-fluorouracil of ERCC1 and gamma-glutamylcysteine synthetase messenger RNA expression in a cisplatin-resistant HST-1 human squamous carcinoma cell line.
    Fujishima H; Nakano S; Masumoto N; Esaki T; Tatsumoto T; Kondo T; Niho Y
    Oncol Res; 1997; 9(4):167-72. PubMed ID: 9268987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemosensitivity correlation between the primary tumors and simultaneous metastatic lymph nodes of patients evaluated by DNA synthesis inhibition assay.
    Nio Y; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
    Cancer; 1990 Mar; 65(6):1273-8. PubMed ID: 2106383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chemosensitivity test for gastric cancer by in vitro MTT assay].
    Ohyama S; Yonemura Y; Kinoshita K; Ninomiya I; Tugawa K; Kimura H; Miyazaki I; Tanaka M; Endo Y; Sasaki T
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1593-7. PubMed ID: 1908213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose cisplatin and 5-fluorouracil in combination can repress increased gene expression of cellular resistance determinants to themselves.
    Nishiyama M; Yamamoto W; Park JS; Okamoto R; Hanaoka H; Takano H; Saito N; Matsukawa M; Shirasaka T; Kurihara M
    Clin Cancer Res; 1999 Sep; 5(9):2620-8. PubMed ID: 10499641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line.
    Singh SV; Xu BH; Jani JP; Emerson EO; Backes MG; Rihn C; Scalamogna D; Stemmler N; Specht S; Blanock K
    Int J Cancer; 1995 May; 61(3):431-6. PubMed ID: 7729958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Flow cytometric DNA analysis and chemosensitivity in squamous cell carcinoma of the head and neck].
    Miyagi M; Soda T; Nakashima T
    Nihon Jibiinkoka Gakkai Kaiho; 1994 Dec; 97(12):2247-58. PubMed ID: 7861297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy of hepatic arterial infusion of adriamycin and mitomycin C mixed with degradable starch microspheres for liver metastasis of colorectal cancer--correlation with the mRNA expression of DNA topoisomerase-IIalpha and glutathione-S transferase-pi in primary lesions].
    Ishida H; Shirakawa K; Takeuchi I; Nakada H; Ohsawa T; Hayashi Y; Okada N; Yokoyama M; Inokuma S; Hashimoto D; Osada H; Matsumoto Y; Miura T
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1803-5. PubMed ID: 15553721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitivity to six antitumor drugs differs between primary and metastatic liver cancers.
    Kanematsu T; Maehara Y; Kusumoto T; Sugimachi K
    Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1511-3. PubMed ID: 2846313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfection of glutathione S-transferase (GST)-pi antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalan, and etoposide.
    Ban N; Takahashi Y; Takayama T; Kura T; Katahira T; Sakamaki S; Niitsu Y
    Cancer Res; 1996 Aug; 56(15):3577-82. PubMed ID: 8758929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of pi glutathione S-transferase in intestinal metaplasia and its relationship with Helicobacter pylori infection].
    Wang X; Wang L; Yuan Y
    Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(15):1033-6. PubMed ID: 12194793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of postoperative adjuvant chemotherapy responders in non-small cell lung cancer by novel biomarker.
    Hirano T; Kato H; Maeda M; Gong Y; Shou Y; Nakamura M; Maeda J; Yashima K; Kato Y; Akimoto S; Ohira T; Tsuboi M; Ikeda N
    Int J Cancer; 2005 Nov; 117(3):460-8. PubMed ID: 15900595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression and amplification of glutathione S-transferase pi gene in head and neck squamous cell carcinomas.
    Wang X; Pavelic ZP; Li Y; Gleich L; Gartside PS; Pavelic L; Gluckman JL; Stambrook PJ
    Clin Cancer Res; 1997 Jan; 3(1):111-4. PubMed ID: 9815545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doxorubicin-induced DNA intercalation and scavenging by nuclear glutathione S-transferase pi.
    Goto S; Ihara Y; Urata Y; Izumi S; Abe K; Koji T; Kondo T
    FASEB J; 2001 Dec; 15(14):2702-14. PubMed ID: 11726546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of the expressions of metallothionein, glutathione-S-transferase-pi, and P-glycoprotein in curatively resected gastric cancer.
    Monden N; Abe S; Sutoh I; Hishikawa Y; Kinugasa S; Nagasue N
    Oncology; 1997; 54(5):391-9. PubMed ID: 9260601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of pi-glutathione S-transferase gene (GSTP1) in gastric cancer: lack of correlation with resistance against cis-diamminedichloroplatinum (II).
    Kodera Y; Akiyama S; Isobe K; Kondo K; Ito K; Yamauchi M; Takagi H
    Eur J Cancer; 1994; 30A(14):2158-62. PubMed ID: 7857716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between expression of drug-resistance factors and drug sensitivity in normal human renal proximal tubular epithelial cells in comparison with renal cell carcinoma.
    Asakura T; Imai A; Ohkubo-Uraoka N; Kuroda M; Iidaka Y; Uchida K; Shibasaki T; Ohkawa K
    Oncol Rep; 2005 Sep; 14(3):601-7. PubMed ID: 16077962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of MDR1 and glutathione S transferase-pi genes and chemosensitivities in human gastrointestinal cancer.
    Satta T; Isobe K; Yamauchi M; Nakashima I; Takagi H
    Cancer; 1992 Feb; 69(4):941-6. PubMed ID: 1735085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multidrug resistance-associated protein expression in clinical gastric carcinoma.
    Endo K; Maehara Y; Ichiyoshi Y; Kusumoto T; Sakaguchi Y; Ohno S; Sugimachi K
    Cancer; 1996 Apr; 77(8 Suppl):1681-7. PubMed ID: 8608562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.